Form 424B7 - Prospectus [Rule 424(b)(7)]:
SEC Accession No. 0001140361-24-042487
Filing Date
2024-10-01
Accepted
2024-10-01 16:36:47
Documents
9

Document Format Files

Seq Description Document Type Size
1 424B7 ny20033174x7_424b7.htm 424B7 5670072
2 logo_cartesian.jpg GRAPHIC 51818
3 logo_cartesianx1.jpg GRAPHIC 58064
4 ny20033174x7_diagram01.jpg GRAPHIC 238752
5 ny20033174x7_diagram02.jpg GRAPHIC 123565
6 ny20033174x7_diagram03.jpg GRAPHIC 155500
7 ny20033174x7_linecharts01.jpg GRAPHIC 300512
8 ny20033174x7_linecharts02.jpg GRAPHIC 219493
9 ny20033174x7_safety.jpg GRAPHIC 519606
  Complete submission text file 0001140361-24-042487.txt   7965936
Mailing Address 704 QUINCE ORCHARD RD GAITHERSBURG MD 20878
Business Address 704 QUINCE ORCHARD RD GAITHERSBURG MD 20878 617-923-1400
Cartesian Therapeutics, Inc. (Filer) CIK: 0001453687 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B7 | Act: 33 | File No.: 333-281204 | Film No.: 241343867
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)